ReviewActa pharmacologica Sinica2026

Mitochondrial antiviral signalling protein (MAVS) in cardiovascular diseases (CVD): a novel pharmacological target.

Baraka Simon Mayamba et al.PubMed ↗Publisher ↗

No numbers read from the abstract.